Skip to main content

Newsroom

Please see below links to the most recent news and events for IDEAYA.

 

Media Contacts News Alerts LinkedIn

 
Latest Press
Nov 18, 2024

Brings over 20-year global commercialization experience in oncology with leading biopharmaceutical companies Gilead Sciences and Bristol Myers Squibb, including leadership of multiple commercial...

Nov 12, 2024

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the Jefferies...

Nov 11, 2024

Nominated IDE034 (BCG034) as a development candidate, a potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody drug conjugate (BsADC) Option exercised for an exclusive worldwide...

All News

Featured Stories
Stay up-to-date with us
GET EMAIL ALERTS
* Required Fields
Close Menu